Literature DB >> 30258662

Adenolipoleiomyoma Polyp of the Uterus: A Case Report and Review of the Literature.

Xavier Catteau1,2, Vincent Anaf3, Jean-Christophe Noël2.   

Abstract

Adenolipoleiomyoma is a very rare lesion of the uterus. Only four cases were reported. We describe one case of adenolipoleiomyoma presenting as a polyp in a postmenopausal woman with menorrhagia. Adenolipoleiomyoma is a very rare lesion and the histogenesis remains unclear. We discuss the origin and the differential diagnosis of this lesion.

Entities:  

Year:  2018        PMID: 30258662      PMCID: PMC6146677          DOI: 10.1155/2018/5704382

Source DB:  PubMed          Journal:  Case Rep Pathol        ISSN: 2090-679X


1. Introduction

An adenolipoleiomyoma is a very rare lesion of the uterus. This is a type of adenomyomatous polyp that contains müllerian-type glands, smooth muscle, and adipose tissue. Only four reports of adenolipoleiomyoma have been described [1-4]. One of them had an aggressive behaviour with recurrence [1].

2. Case Presentation

This is a fifty-five-year-old woman with past appendectomy. She was perimenopausal and had no treatment. Her brother had a rectum neoplasia. She had four children. She suffered from anemia because she had menorrhagia since few months. Ultrasonography examination revealed a polymyomatous uterus and a vascularized polyp of 23x17 mm in the uterine cavity. Mammography and breast ultrasonography were normal. CA125 was high (63,3 U/ml). Total hysterectomy with bilateral ovariectomy was performed because its symptoms lasted for too long. Histological examination showed a subatrophic endometrium with bands of irregular proliferation, slight-to-moderate adenomyosis, and benign subserosal leiomyoma of 34 mm in size. There was also a pedunculated polyp of 25 mm. Macroscopically, this polyp appeared white, fibrous, fasciculated, and focally yellow (Figure 1). Microscopically, we observed endometrial glands with a stroma composed of smooth muscle and adipocytes (Figure 2). The zone appearing macroscopically fatty contained mature adipose tissue. No atypia was observed. The adipocytes were positive for estrogen and progesterone receptor. A diagnosis of adenolipoleiomyoma was made. No specific particularities were revealed in the follow-up at two years.
Figure 1

Macroscopically, this polyp appeared white, fibrous, fasciculate (glandular component, double arrow), and focally yellow (one arrow).

Figure 2

Lesion at low power-view with smooth muscle, glands, and adipocytes (one arrow) components. Lesion with adipocytic (center of the lesion, arrow) and glandular components (X20).

3. Discussion

Adenolipoleiomyoma is a rare polypoid uterine lesion composed of müllerian-type glands (glands of müllerian origin like endometrium), smooth muscle, and adipose tissue. The histogenesis of this lesion remains controversial. Mc Cluggage et al. and Payne et al. believe that uterine adenolipoleiomyoma is a benign hamartomatous lesion. They think that lesion represents a hamartomatous lesion with adipocytic metaplasia, a sort of direct metaplasia from a preexisting tissue present normally in the uterus [2, 3]. Yavuz suggests that it is a variant of benign müllerian mixed tumour [1]. Ridvan et al. think that their case presents features of hamartoma: adipose tissue and thick-walled vascular structures intensely admixed and the absence of internal elastic lamina in the arteriolar structures [5]. However, they described cases of müllerian adenosarcoma and rhabdomyosarcoma of the uterine cervix with heterologous mesenchymal elements, such as cartilage and fatty tissue. They think that this type of lesion is a müllerian-type lesion, because müllerian stromal cells have the capacity to be transformed into other mesenchymal-type cells [5]. The case described by Shaco-Levy et al. with an aggressive behaviour could be an atypical müllerian lesion rather than a hamartoma. In our case, we think that is a hamartoma with direct adipocytic metaplasia. The fact that no atypia was observed and the presence of benign endometrial glands and smooth muscle are in support of a hamartomatous origin. Nevertheless, our case is the only one associated with adenomyosis and a differential diagnosis must be made between adenolipoleiomyoma and lipoleiomyoma involved by adenomyosis. In our case, a well-demarcated lesion with central fatty zone is an argument for adenolipoleiomyoma (Figure 1). The slight elevation of Ca 125 may be due to adenomyosis but this data is not clearly found in the literature. No association between adenolipoleiomyoma and Ca 125 was reported. In the literature, the mean age is 45.8 years and the mean size of tumour is 5.2 cm. One case has been described in cervix [4]. Hysterectomy is the most frequent treatment but depends on the age of the patient. Table 1 summarizes the cases described in literature.
Table 1

Clinical and pathological features of the current tumor and uterine adenolipoleiomyoma reported in the literature.

AuthorsAge (yr)PresentationTumor locationTumor largest diameter (cm)HistologyTherapyOutcome, Follow-up
Payne et al.19Irregular vaginal bleedingPolypoid endometrial mass2.5Smooth muscle, endometrial stroma, adipose tissue, endometrioid-type epitheliumPolypectomyNED, 1 yr

McCluggage et al.53Incidental finding in a patient with retrovaginal prolapseIntramural uterine mass2.5Smooth muscle, endometrial stroma, adipose tissue, endometrioid, endocervical and tubal-type epitheliumHysterectomyNone

Yavus et al.52Lower abdominal pain and postmenopausal bleedingPolypoid endometrial mass7.0Smooth muscle, endometrial stroma, adipose tissue, endometrioid-type epitheliumHysterectomy and bilateral salpingo-oophorectomyNone

Shaco-Levy et al.40Pelvic mass.Intramural and subserosal masses1st resection: 162nd resection: 43First resection: smooth muscle, adipose tissue, endocervical-type epitheliumSecond resection: smooth muscle, adipose tissue, endometrial-type stroma, endocervical-type epithelium, focally atypically proliferating, and endometrioid-type epithelium1st resection: conservative excision masses2nd resection: total hysterectomy, bilateral salpingo-oophorectomy and resection of tumor masses.Local recurrence after 16 monthsSecond resection:NED after 4 months

Current case.55Irregular vaginal bleedingIntraluminal uterine polyp2.5Smooth muscle, adipose tissue, endometrioid-type epitheliumTotal hysterectomy, bilateral salpingo-oophorectomyNED, 6 months

∗NED indicates no evidence of disease.

Differential diagnoses are atypical polypoid adenomyoma that contains an architecturally complex and cytological atypical glandular component, whereas adenomyomatous polyp has simple glands and no significant atypia [6]; lipoleiomyoma involved by adenomyosis: in this type of lesion the structures are not clearly mixed; adenomyoma with adipocytic metaplasia that differs from adenolipoleiomyoma by the aspect of adipocytes (more irregular); benign variant of mixed müllerian tumour that contains very rarely three components; adenosarcoma that exhibits a more complex pattern of spindle cells with mitoses; common uterine leiomyoma that contains no glandular component [1, 7].

4. Conclusion

Adenolipoleiomyoma is very rare and the histogenesis of this lesion remains unclear. Although this tumour seems to be most frequently benign, prolonged follow-up will be necessary to confirm this benignity [2].
  6 in total

1.  Hamartomatous endocervical polyp with heterologous mesenchymal tissue.

Authors:  R Ilhan; E Yavuz; A Iplikçi; S Tuzlali
Journal:  Pathol Int       Date:  2001-04       Impact factor: 2.534

2.  Adenomyomatous polyp mimicking hydatidiform mole on ultrasonography.

Authors:  M Furuhashi; Y Miyabe; H Oda
Journal:  Arch Gynecol Obstet       Date:  2000-04       Impact factor: 2.344

3.  Adenomyolipoma of the endometrium--a hamartoma?

Authors:  F Payne; T P Rollason; E Sivridis
Journal:  Histopathology       Date:  1992-04       Impact factor: 5.087

4.  Uterine adenolipoleiomyoma: a tumor with potential of aggressive behavior.

Authors:  Ruthy Shaco-Levy; Benjamin Piura
Journal:  Int J Gynecol Pathol       Date:  2008-04       Impact factor: 2.762

Review 5.  Uterine adenomyoma: a clinicopathologic review of 26 cases and a review of the literature.

Authors:  Anita Tahlan; Annu Nanda; Harsh Mohan
Journal:  Int J Gynecol Pathol       Date:  2006-10       Impact factor: 2.762

6.  Uterine adenolipoleiomyoma: a rare hamartomatous lesion.

Authors:  W G McCluggage; P Hamal; A I Traub; M Y Walsh
Journal:  Int J Gynecol Pathol       Date:  2000-04       Impact factor: 2.762

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.